Clinical trial for new tuberculosis vaccine
Thursday, September 11, 2008 - 10:14
in Health & Medicine
Since Monday of this week, the new vaccine "VPM1002" has entered the clinical phase I trial in Neuss, Germany, where it is being tested for safety on voluntary subjects. VPM1002 is based on a vaccine that has been in use since 1921, and has been genetically engineered to prevent infection with tuberculosis bacteria much more effectively than its predecessor.
Read the whole article on Physorg
More from Physorg
Related
- Novel tuberculosis vaccine in Germany in clinical phaseThu, 11 Sep 2008, 11:16:59 EDT
- Clinical trial for new tuberculosis vaccineThu, 11 Sep 2008, 11:16:52 EDT
- India continues to progress in AIDS vaccine development effortsMon, 18 Aug 2008, 0:22:02 EDT
- TB vaccine gets its groove backTue, 19 May 2009, 14:50:51 EDT
- New test may help to ensure that dengue vaccines do no harmThu, 12 Feb 2009, 14:16:45 EST